Skip to content

Clinical trials

Phase 3 Eczema trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eczema Phase: Phase 3 Country / region: Germany Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20151
20173
20189
20192
20203
20211
20222
20236
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
Pfizer7
Incyte Corporation5
Amgen3
Almirall, S.A.2
Regeneron Pharmaceuticals2
Basilea Pharmaceutica1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eczema31
Dermatitis, Atopic27
Dermatitis9
Skin Diseases8
Pruritus3
Genetic Diseases, Inborn2
Hypersensitivity2
Hypersensitivity, Immediate2
Immune System Diseases2
Skin Diseases, Eczematous2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.